Abstract
Prophylactic surgery is novel for urologic surgery. It is used for preventing the functional loss of the organ, serious medical or surgical conditions, malignant degeneration or to improve aesthetical conditions. However, to the best of our knowledge, preventive or prophylactic surgery has not been properly defined in the urology speciality. Being aware of this, we described prophylactic urological surgeries by combining with the detailed published literature and our clinical practice below. However, we know the difficulties, such as organ sparing surgical modalities, are recently preferable in urology practice and legal/ethical challenge of prophylactic surgical procedures, which is discussed in another chapter of this book. The difficulty is describing the prophylaxis with combining organ function preservation. We hope that the compiled chapter would be a pioneer in its field and would be the pathfinder for clinicians.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kaplan JR, Sung RS, Wolf JS. Bilateral Native Nephrectomy: Before or After Renal Transplantation? UIJ. 2009; 2. https://doi.org/10.3834/uij.1939-4810.2008.12.04.
Brakeman P. Vesicoureteral reflux, reflux nephropathy, and end-stage renal disease. Adv Urol. 2008;2008:508949.
Sargent MA. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000;30(9):587–93.
Ishikura K, Uemura O, Hamasaki Y, Nakai H, Ito S, Harada R, et al. Pediatric CKD Study Group in Japan in conjunction with the committee of measures for pediatric CKD of the Japanese Society for Pediatric Nephrology. Insignificant impact of VUR on the progression of CKD in children with CAKUT. Pediatr Nephrol. 2016;31:105–12.
United States Renal Data System (USRDS). Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007. https://www.usrds.org. Last accessed 4 Aug 2020.
Mishra SK, Muthu V, Rajapurkar MM, Desai MR. Kidney transplantation in abnormal bladder. Indian J Urol. 2007;23(3):299–304.
Papalois VE, Moss A, Gillingham KJ, Sutherland DE, Matas AJ, Humar A. Pre-emptive transplants for patients with renal failure. Transplantation. 2000;70(4):625–31.
Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol. 2005;174(6):2284–8.
Ismail HR, Flechner SM, Kaouk JH, Derweesh IH, Gill IS, Modlin C, et al. Simultaneous vs. sequential laparoscopic bilateral native nephrectomy and renal transplantation. Transplantation. 2005;80(8):1124–7.
Glassman DT, Nipkow L, Bartlett ST, Jacobs SC. Bilateral nephrectomy with concomitant renal graft transplantation for autosomal dominant polycystic kidney disease. J Urol. 2000;164(3 Pt 1):661–4.
Kim JH, Chae SY, Bae HJ, Kim JI, Moon IS, Choi BS, et al. Clinical outcome of simultaneous native nephrectomy and kidney transplantation in patients with autosomal dominant polycystic kidney disease. Transplant Proc. 2016;48(3):840–3.
Elrggal ME, Abd Elaziz HM, Gawad MA, Sheashaa HA. Native nephrectomy in kidney transplantation, when, why, and how? J Egypt Soc Nephrol Transplant. 2018;18:68–72.
Martin AD, Mekeel KL, Castle EP, Vaish SS, Martin GL, Moss AA, et al. Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation. BJU Int. 2012;110(11 Pt C):E1003–7.
Babu R, Ragoori D. Bladder augmentation: distal ureterocystoplasty with proximal ureteric reimplantation: a novel technique. J Indian Assoc Pediatr Surg. 2012;17(4):165–7.
Bellinger MF. Ureterocystoplasty: a unique method for vesical augmentation in children. J Urol. 1993;149:811–3.
Kajbafzadeh AM, Farrokhi-Khajeh-Pasha Y, Ostovaneh MR, Nezami BG, Hojjat A. Teapot ureterocystoplasty and ureteral Mitrofanoff channel for bilateral megaureters: technical points and surgical results of neurogenic bladder. J Urol. 2010;183:1168–74.
Dinckan A, Kocak H, Tekin A, Turkyilmaz S, Hadimioglu N, Ertug Z, et al. Concurrent unilateral or bilateral native nephrectomy in kidney transplant recipients. Ann Transplant. 2013;18:697–704.
Sutters M, Germino GG. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med. 2003;141:91–101.
Gabw PA. Autosomal dominant polycystic kidney disease. N Engl J Med. 1993;329:332–42.
Sulikowski T, Tecjhman K, Zietek Z, Rózański J, Domański L, Kamiński M, et al. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation. Transplant Proc. 2009;41(1):177–80.
Rozanski J, Kozlowska I, Myslak M, Domanski L, Sienko J, Ciechanowski K, et al. Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplant Proc. 2005;37:666–8.
Gozen AS, Gherman V, Akin Y, Bolat MS, Elmussareh M, Rassweiler J. Evaluation of the complications in laparoscopic retroperitoneal radical nephrectomy; an experience of high volume centre. Arch Ital Urol Androl. 2017;89(4):266–71.
Akin Y, Gulmez H, Güntekin E, Baykara M, Yucel S. Retrospective study of endoscopic treatment in children with primary VUR and multivariate analysis of factors for failure. Scand J Urol. 2014;48(6):565–70.
Tekgül S, Riedmiller H, Hoebeke P, Kočvara R, Nijman RJ, Radmayr C, et al. European Association of Urology. EAU guidelines on vesicoureteral reflux in children. Eur Urol. 2012;62:534–42.
Kirsch A, Hensle T, Scherz H, Koyle M. Injection therapy: advancing the treatment of vesicoureteral reflux. J Pediatr Urol. 2006;2:539–44.
Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol. 2010;184:1134–44.
Elmore JM, Kirsch AJ, Heiss EA, Gilchrist A, Scherz HC. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation. J Urol. 2008;179:2364–7.
Yu RN, Roth DR. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon. Pediatrics. 2006;118:698–703.
https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Paediatric-Urology-2018-large-text.pdf. Last accessed 15 Jun 2020.
Pham KN, Jeldres C, Hefty T, Corman JM. Endoscopic management of bladder diverticula. Rev Urol. 2016;18(2):114–7.
Rovner ES. Bladder and female urethral diverticula. In: McDougal S, editor. Campbell-Walsh urology. Amsterdam: Elsevier; 2012. p. 2262–71.
Orandi A. Transurethral fulguration of bladder diverticulum: new procedure. Urology. 1977;10:30–2.
Grønlund A, Lendorf A, Lauritzen AF, Kvist E. Bladder diverticulectomy: operative technique. Scand J Urol Nephrol. 1998;32:98–101.
Tufek I, Mourmouris P, Omer Argun OB, Obek C, Keskin MS, Akpinar H, et al. Robot-assisted bladder diverticulectomy with concurrent management of bladder outlet obstruction. Urol Int. 2016;96(4):432–7.
Descazeaud A, Robert G, de La Taille A. Management of the bladder outlet obstruction is associated with BPH in patients with special circumstances and/or complications. Prog Urol. 2018;28(15):868–74.
Bauer SB. Neurogenic bladder: etiology and assessment. Pediatr Nephrol. 2008;23(4):541–51.
Lapides J, Diokno AC, Silber SJ, et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease. Trans Am Assoc Genitourin Surg. 1971;63:92–6.
Blais AS, Nadeau G, Moore K, Genois L, Bolduc S. Prospective pilot study of mirabegron in pediatric patients with overactive bladder. Eur Urol. 2016;70(1):9–13.
Khan MK, VanderBrink BA, DeFoor WR, Minevich E, Jackson E, Noh P, et al. Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder. J Pediatr Urol. 2016;12(2):104.e1–6.
Greer T, Abbott J, Breytenbach W, McGuane D, Barker A, Khosa J, et al. Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children. J Pediatr Urol. 2016;12(2):94.e1–6.
Grimsby GM, Menon V, Schlomer BJ, Baker LA, Adams R, Gargollo PC, et al. Long-term outcomes of bladder neck reconstruction without augmentation cystoplasty in children. J Urol. 2016;195(1):155–61.
Szymanski KM, Misseri R, Whittam B, Adams CM, Kirkegaard J, King S, et al. Mortality after bladder augmentation in children with spina bifida. J Urol. 2015;193(2):643–8.
Watanabe T, Rivas DA, Smith R, Chancellor MB. The effect of urinary tract reconstruction on neurologically impaired women previously treated with an indwelling urethral catheter. J Urol. 1996;156(6):1926–8.
Roth JD, Cain MP. Neuropathic bladder and augmentation cystoplasty. Urol Clin North Am. 2018;45(4):571–85.
Golomb J, Klutke CG, Lewin KJ, Goodwin WE, deKernion JB, Raz S. Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review. J Urol. 1989;142(2 Pt 1):377–80.
Karafin L, Kendall AR. Vesicostomy in the management of neurogenic bladder disease secondary to meningomyelocele in children. J Urol. 1966;96(5):723–8.
Wiener JS, Antonelli J, Shea AM, Curtis LH, Schulman KA, Krupski TL, et al. Bladder augmentation versus urinary diversion in patients with spina bifida in the United States. J Urol. 2011;186(1):161–5.
Capizzi A, Zanon GF, Zacchello G, Rigamonti W. Kidney transplantation in children with reconstructed bladder. Transplantation. 2004;77:1113–6.
Russ G. Where did we leave off in 2008? Conclusions from the 8th international symposium. Transplant Proc. 2009;41(6 Suppl):S27–30.
Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236–7.
Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004;172:839–45.
Woodworth D, Mayer E, Leu K, Ashe-McNalley C, Naliboff BD, Labus JS, et al. Unique microstructural changes in the brain associated with urological chronic pelvic pain syndrome (UCPPS) revealed by diffusion tensor MRI, super-resolution track density imaging, and statistical parameter mapping: a MAPP network neuroimaging study. PLoS One. 2015;10:e0140250.
Krieger JN, Riley DE, Cheah PY, Liong ML, Yuen KH. Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol. 2003;21(2):70–4.
Schoeb DS, Schlager D, Boeker M, Wetterauer U, Schoenthaler M, Herrmann TR, et al. Surgical therapy of prostatitis: a systematic review. World J Urol. 2017;35(11):1659–68.
Kaplan SA, Te AE, Jacobs BZ. Urodynamic evidence of vesical neck obstruction in men with misdiagnosed chronic nonbacterial prostatitis and the therapeutic role of endoscopic incision of the bladder neck. J Urol. 1994;152:2063–5.
Schaeffer AJ, Datta NS, Fowler JE Jr, Krieger JN, Litwin MS, Nadler RB, et al. Chronic prostatitis collaborative research network overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology. 2002;60(6 Suppl):1–4.
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–97.
Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008;31(Suppl 1):S85–90.
Rassweiler J, Teber D, Kuntz R, Hoffman R. Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol. 2006;50:969–79.
Kang M, Kim M, Choo MS, Bae J, Ku JH, Yoo C, et al. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Urology. 2014;84(6):1461–6.
De la Rosette J, Alivizatos G, Madersbacher S, Perachino M, Thomas D, Desgrandchamps F, et al. EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol. 2001;40:2–63.
Kaplan SA. Side effects of alpha-blocker use: retrograde ejaculation. Rev Urol. 2009;11:S14–8.
Dmochowski RR. Bladder outlet obstruction: etiology and evaluation. Rev Urol. 2005;7(Suppl 6):S3–13.
Alloussi SH, Lang C, Eichel R, Alloussi S. Ejaculation-preserving transurethral resection of prostate and bladder neck: short- and long-term results of a new innovative resection technique. J Endourol. 2014;28:84–9.
Ku JH, Ko DW, Cho JY, Oh SJ. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms. Urology. 2010;75:1467–71.
Yang SS, Tsai YC, Chen JJ, Peng CH, Hsieh JH, Wang CC. Modified transurethral incision of the bladder neck treating primary bladder neck obstruction in young men: a method to improve voiding function and to preserve antegrade ejaculation. Urol Int. 2008;80:26–30.
Anwar MS, Munawar F, Anwar Q. Circumcision: a religious obligation or ‘the cruellest of cuts’? Br J Gen Pract. 2010;60(570):59–61.
Rizvi SA, Naqvi SA, Hussain M, Hasan AS. Religious circumcision: a Muslim view. BJU Int. 1999;83(Suppl 1):13–6.
Ntombana L. Should Xhosa male initiation be abolished? Int J Cult Stud. 2011;14:631–40.
Cawte JE, Djagamara N, Barrett MG. The meaning of subincision of the urethra to aboriginal Australians. Br J Med Psychol. 1966;39:245–53.
Prabhakaran S, Ljuhar D, Coleman R, Nataraja RM. Circumcision in the paediatric patient: a review of indications, technique and complications. J Paediatr Child Health. 2018;54(12):1299–307.
Morris BJ, Wamai RG, Henebeng EB, Tobian AA, Klausner JD, Banerjee J, et al. Estimation of country-specific and global prevalence of male circumcision. Popul Health Metrics. 2016;14:4.
Abdulwahab-Ahmed A, Mungadi IA. Techniques of male circumcision. J Surg Tech Case Rep. 2013;5(1):1–7.
Shapiro E. American Academy of Pediatrics policy statements on circumcision and urinary tract infection. Rev Urol. 1999;1:154–6.
Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child. 2005;90:853–8.
Mukherjee S, Joshi A, Carroll D, Chandran H, Parashar K, McCarthy L. What is the effect of circumcision on risk of urinary tract infection in boys with posterior urethral valves? J Pediatr Surg. 2009;44(2):417–21.
Morris BJ, Wiswell TE. Circumcision and lifetime risk of urinary tract infection: a systematic review and meta-analysis. J Urol. 2013;189:2118–24.
Frisch M, Aigrain Y, Barauskas V, Bjarnason R, Boddy SA, Czeuderna P, et al. Cultural bias in the AAP’s 2012 technical report and policy statement on male circumcision. Pediatrics. 2013;131:796–800.
Tseng HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001;12:267–77.
Sewell J, Ranasinghe W, De Silva D, Ayres B, Ranasinghe T, Hounsome L, et al. Trends in penile cancer: a comparative study between Australia, England and Wales, and the US. Springerplus. 2015;4:420.
https://www.cancer.org/cancer/penile-cancer/causes-risks-prevention/prevention.html. Last accessed 17 Jun 2020.
Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009;2:CD003362.
Szabo R, Short RV. How does male circumcision protect against HIV infection? BMJ. 2000;320(7249):1592–4.
https://www.who.int/whr/media_centre/factsheet1/en/. Last accessed 17 Jun 2020.
Balci M, Tuncel A, Baran I, Guzel O, Keten T, Aksu N, et al. High-risk oncogenic human papilloma virus infection of the foreskin and microbiology of Smegma in Prepubertal boys. Urology. 2015;86:368–72.
Shirazi M, Farsiani M, Natami M, Izadpanah K, Malekahmadi A, Khakbaz A. Which patients are at higher risk for residual valves after posterior urethral valve ablation? Korean J Urol. 2014;55:64–8.
Ipekci T, Akin Y, Gulmez H, Ates E, Yucel S. Impact of transurethral resection on urinary flow rate in children with posterior urethral valve in short term follow-up. Saudi Med J. 2014;35:460–5.
https://www.auajournals.org/doi/abs/10.1016/j.juro.2014.05.005. Last accessed 17 Jun 2020.
Barthold JS. Abnormailities of the testis and scrotum and their surgical management. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 10th ed. Philadelphia: Saunders; 2012. p. 3560–74.
Ferguson L, Agoulnik AI. Testicular cancer and cryptorchidism. Front Endocrinol (Lausanne). 2013;4:32.
Thorup J, McLachlan R, Cortes D, Nation TR, Balic A, Southwell BR, et al. What is new in cryptorchidism and hypospadias—a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg. 2010;45(10):2074–86.
Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007;356(18):1835–41.
Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. European Association of Urology. Guidelines on testicular cancer: 2015 update. Eur Urol. 2015;68:1054–68.
Chung JM, Lee SD. Individualized treatment guidelines for postpubertal cryptorchidism. World J Mens Health. 2015;33(3):161–6.
Rogers E, Teahan S, Gallagher H, Butler MR, Grainger R, McDermott TE, et al. The role of orchiectomy in the management of postpubertal cryptorchidism. J Urol. 1998;159(3):851–4.
Farrer JH, Walker AH, Rajfer J. Management of the postpubertal cryptorchid testis: a statistical review. J Urol. 1985;134(6):1071–6.
Bazzi WM, Raheem OA, Stroup SP, Kane CJ, Derweesh IH, Downs TM. Partial orchiectomy and testis intratubular germ cell neoplasia: world literature review. Urol Ann. 2011;3:115–8.
Ates M, Akin Y. Re: Giuseppe Simone, Umberto Anceschi, Gabriele Tuderti, et al. Robot-assisted partial adrenalectomy for the treatment of Conn’s syndrome: surgical technique, and perioperative and functional outcomes. Eur Urol. 2019;75:811-6. Eur Urol. 2020;78(2):e83–4.
Prajapati OP, Verma AK, Mishra A, Agarwal G, Agarwal A, Mishra SK. Bilateral adrenalectomy for Cushing’s syndrome: pros and cons. Indian J Endocrinol Metab. 2015;19(6):834–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Akın, Y., Laguna, M.D.P., De La Rosetta, J. (2021). Prophylactic Surgery for Urologic Pathologies. In: Dilek, O.N., Uranues, S., Latifi, R. (eds) Prophylactic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-66853-2_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-66853-2_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-66852-5
Online ISBN: 978-3-030-66853-2
eBook Packages: MedicineMedicine (R0)